Layoffs hit another biotech as Duchenne player Solid Bio cuts staff by 35% - Endpoints News

4/27/2022 12:00:00 AM3 yearsago
by Max Gelman

Another biotech has joined the ranks of the reorganized, as Duchenne player Solid Biosciences reported a new way of doing things Wednesday and announced layoffs and a C-suite departure. Solid Bio is reducing its workforce by 35%, according to an SEC filing fo…

An­oth­er biotech has joined the ranks of the re­or­ga­nized, as Duchenne play­er Sol­id Bio­sciences re­port­ed a new way of do­ing things Wednes­day and an­nounced lay­offs and a C-suite de­par­tur… [+3456 chars]

full article...